Chronic Stroke, Subacute Stroke
Conditions
Brief summary
The aim of this study was to investigate the effects of lower limb constraint induced motor therapy using the robotic rehabilitation device on ambulatory function in chronic stroke patients.
Interventions
DEVICEexperimental group
The treatment comprised 5 robot-assisted gait training sessions over a 2-week period, followed by 10 lower limb Constraint Induced Movement Therapy(CIMT) sessions with a torque assisted exoskeleton.
Sponsors
Samsung Medical Center
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Adults aged 19 years or older * Patients with hemiparesis due to ischemic or hemorrhagic stroke * Patients in the late subacute or chronic phase, at least 3 months after the onset of stroke * Individuals who can independently walk with a Functional Ambulatory Category score of 3 or higher * Patients who are able to use Torque-Assisted Exoskeletal Wearable Device Height: 140 cm to 190 cm Weight: 80 kg or less Shoe size: 230 mm to 290 mm * Patients who were independent walkers and had no difficulties performing activities of daily living (mRS ≤ 1)
Exclusion criteria
* Patients with severe cognitive impairment (MMSE \<10) or significant communication difficulties such as speech disorders * Patients with spasticity in one-sided lower limbs, rated 2 or higher on the Modified Ashworth Scale (MAS) * Patients with severe musculoskeletal disorders of the lower limbs * Patients with contractures that limit the range of motion in the lower limbs * Patients with an apparent leg length discrepancy of 2 cm or more * Patients with fractures, open trauma, or non-healing ulcers in the lower limbs * Patients with serious internal diseases such as cardiovascular disease or pulmonary disease that make it difficult to use Exoskeletal Wearable Device for walking therapy * Patients with a history of osteoporotic fractures * Patients with other neurological disorders affecting walking (e.g., Parkinson's disease, multiple sclerosis, etc.) * Any other cases where the investigator determines that participation in this study is inappropriate
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Comparison of the change in walking speed | 3 weeks follow up | Comparison of the change in walking speed before and after 5 sessions of walking training versus 10 sessions of CIMT exercise training |
Countries
South Korea
Outcome results
None listed